Till date,the state government has not placed a single tender for these syringes
With the outbreak of the mutated Hepatitis B virus in Modasa reportedly due to the use of infected syringes attracting attention all across the country,companies dealing in health infrastructure facilities are now showing a keen interest in Gujarat.
Time Technoplast Ltd. (TTL),a Mumbai-based polymers product company,on Friday,announced the launch of Auto-Disabled (AD) syringes and Auto Collect Blood Sampler manufactured by its Medical Division Genex Health Care in the state.
The AD syringes automatically lock on first use,while the Auto Collect Blood Sampler is a leak-proof container for collecting blood to cut the risk of cross contamination of blood collected in bottles and test tubes.
Incidentally,Gujarat has not placed a single tender of AD syringes till date,according to the Association of Indian Medical Devices Industries.
State Health Minister Jay Narayan Vyas has also earlier clarified that the government will not use AD syringes in the near future.
Nevertheless,the company plans to tap the private practitioners and hospitals in the state.
The company is also planning to price it between Rs 1.75 and Rs 2.25 to make it cost-effective.
Genex Health Care Vice-President Anil Agni said: We have not yet approached the government,but we plan to approach all the state holders,including the medical institutes,in this regard. We also plan to use posters and other methods to create awareness about the benefits of the product. The fact that Gujarat is located near Mumbai has also triggered interest in the Modasa outbreak,which has once again highlighted the result of unsafe injection practices.